Área Sanitaria de Ourense, Verín e O Barco de Valdeorras
Área sanitaria
Juan
Clofent Villaplana
Investigador ata 2013
Publicacións nas que colabora con Juan Clofent Villaplana (20)
2020
-
Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85
2019
-
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome
Endoscopy, Vol. 51, Núm. 2, pp. 142-151
2018
-
Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update
Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 585-596
2017
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
2016
-
Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study
Gut, Vol. 65, Núm. 11, pp. 1829-1837
-
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
BMC Medicine, Vol. 14, Núm. 1
2014
-
High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families
Clinical Genetics, Vol. 85, Núm. 6, pp. 583-588
-
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4
2013
-
Genetic susceptibility variants associated with colorectal cancer prognosis
Carcinogenesis, Vol. 34, Núm. 10, pp. 2286-2291
-
Risk of cancer in cases of suspected lynch syndrome without germline mutation
Gastroenterology, Vol. 144, Núm. 5
2012
-
COGENT (COlorectal cancer GENeTics) revisited
Mutagenesis, Vol. 27, Núm. 2, pp. 143-151
2011
-
5-fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer
Gastroenterology, Vol. 140, Núm. 4, pp. 1174-1181
-
Case-control study for colorectal cancer genetic susceptibility in EPICOLON: Previously identified variants and mucins
BMC Cancer, Vol. 11
2010
-
Colorectal cancer prognosis twenty years later
World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867
-
Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype
Gastroenterology, Vol. 139, Núm. 3
2009
-
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
European Journal of Cancer, Vol. 45, Núm. 3, pp. 365-373
2008
-
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients
Journal of Medical Genetics, Vol. 45, Núm. 9, pp. 557-563
2006
-
Diagnostic yield and clinical outcomes after capsule endoscopy in 100 consecutive patients with obscure gastrointestinal bleeding
European Journal of Gastroenterology and Hepatology, Vol. 18, Núm. 8, pp. 881-888
-
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
Gut, Vol. 55, Núm. 6, pp. 848-855
1996
-
Biliopancreatic ascariasis: an infrequent disease in our environment
Gastroenterología y hepatología, Vol. 19, Núm. 4, pp. 210-212